Announcements Trials
Browse Landscape

Phase

Phase 2 77Phase 1 71Phase 1/2 30Phase 3 14Phase NA 4Phase EARLY_PHASE1 2Phase 2/3 2Phase 4 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Leukemia, Myeloid, Acute 1Ependymoma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Azacitidine × Clear all
NCT04518345 2023-02-06

TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
3 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02940483 2018-11-30

5-AZA

The University of Texas Health Science Center, Houston

Phase EARLY_PHASE1 Completed
6 enrolled
CNS

Brain Neoplasms, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡